Personnel

Stem cell pioneer Dr. Nelson Chao named to advisory board

Published in Gene Therapy Weekly, May 13th, 2004

NeoStem, a company committed to pioneering adult stem cell therapeutics, announced that Nelson Chao, MD, MBA, professor of medicine and immunology, and chief, division of cellular therapy/BMT (bone marrow transplantation), Duke University, has been named to the firm's medical advisory board.

As the first company enabling individuals to bank their own stem cells for future medical treatments, Chao brings to NeoStem a wealth of experience in stem cell and cancer research, and BMT. As a NeoStem medical advisory board member, he will provide professional counsel to the company, with a focus on clinical trials, adult stem-cell research, and new therapeutic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2004-05-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry